You are here: vision-research.eu » People » Research Groups » United Kingdom » Coupland, Sarah

Liverpool Ocular Oncology Research Group (LOORG)

The Liverpool Ocular Oncology Research Group’s (LOORG’s) mission is to conduct high quality basic, translational and clinical research into the pathogenesis and treatment of adult ocular tumours that will improve patient care and survival. The Liverpool Ocular Oncology Research Group (LOORG) was established by Professor Sarah Coupland and Professor Bertil Damato in 2006. Prof. Coupland has since lead the basic science and translational research portfolio, in addition to being a Consultant Pathologist at the Royal Liverpool University Hospital.

A major strength of the LOORG is the close collaboration between ocular oncology clinicians (Lead, Professor Heimann), pathologists and basic scientists (Dr Sarah Lake and Dr Helen Kalirai) which ensures that the research we conduct addresses the key questions that will bring about improved survival and quality of life for ocular oncology patients.

Group Leader

Sarah E. Coupland
[more information]

Contact

University of Liverpool

Molecular and Clinical Cancer Medicine
Institute of Translational Medicine
6th Floor, Duncan Building
L69 3GA Liverpool
United Kingdom

Phone: +44(0)151 706 4494
Fax: +44(0)151 706 5826

E-mail:
s.e.coupland[at]liverpool.ac.uk

Website:
www.loorg.org

Current Research Projects

  • Project 1:
    Identification of regulators of metastasis in uveal melanoma
  • Project 2:
    Proteomic discovery of serum biomarkers in metastatic uveal melanoma
  • Project 3:
    Estimating survival prognosis after treatment of choroidal melanoma
  • Project 4:
    Gross chromosomal abnormalities in iris melanoma
  • Project 5:
    Molecular characteristics of metastatic liver lesions in uveal melanoma: the search for therapeutic targets

Research Groups

People

Related Research Groups

clinical laboratory testing
Oops, an error occurred! Code: 20200331004121700c42f1
conjunctiva
Oops, an error occurred! Code: 20200331004121fd029ca1
disease gene mapping
Oops, an error occurred! Code: 20200331004121aea0d177
gene/expression
Oops, an error occurred! Code: 202003310041211558533b
gene microarray
Oops, an error occurred! Code: 2020033100412127cffc76
genetics
Oops, an error occurred! Code: 20200331004121c97e4c32
immunohistochemistry
Oops, an error occurred! Code: 202003310041217e6de86c
iris
Oops, an error occurred! Code: 20200331004121b2a9c99f
melanoma
Oops, an error occurred! Code: 2020033100412165ff2d41
oncology
Oops, an error occurred! Code: 20200331004121b641bf02
pathology: experimental
Oops, an error occurred! Code: 20200331004121c48c5e16
pathology: human
Oops, an error occurred! Code: 202003310041217628816f
pathology techniques
Oops, an error occurred! Code: 20200331004121d7cdb8e8
tumors
Oops, an error occurred! Code: 2020033100412146d1d17b
uvea
Oops, an error occurred! Code: 2020033100412178681a31
vision and action
Oops, an error occurred! Code: 202003310041210a73440f
visual acuity
Oops, an error occurred! Code: 202003310041216d8a5ff1
uveal melanoma
Oops, an error occurred! Code: 202003310041213bcf1b99
conjunctival melanoma
Oops, an error occurred! Code: 20200331004121d22f1e39
intraocular and ocular adnexal lymphomas
Oops, an error occurred! Code: 20200331004121cf99d9f2
pathology
Oops, an error occurred! Code: 20200331004121cca148c5
translational studies
Oops, an error occurred! Code: 20200331004121cc00e2bd